decaro

HGEN: log chart of a COVID-related trade

NASDAQ:HGEN   None
Humanigen is due to present major data from Phase III trials at three conferences in mid-March. The stock is in multiple wedges, and a breakout or breakdown seems highly likely.

Shares are currently trending sideways --- in my opinion, as investors await the outcomes of these events.

When it comes, the move is likely to be explosive. Thus, implied volatility is presently quite high. Normally, I would be tempted to sell a straddle. But I think that realized volatility may exceed implied volatility in this case. Just a guess!

I am buying long ATM straddles here with the April 16 expiration. I am also buying shares of the stock on this week's pullback.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.